ABOUT US

We aim to develop a New Drug for patients suffering from incurable diseases. In order to drastically reduce the lead time, we utilize AI tech to intensify the modern knowledge and creative human approach, verifying them with biologically experiments, to gain the critical technology for disease cure.

SapiensBio
Co-President/CEO
Dr. Ryoo, Kanghyun
SapiensBio
Co-President/CEO
Dr. Ryu, Incheol
- Edu
-
- Korea University Biochemistry Ph.D.
- Profession
-
- Biochemistry & Neurobiology
- Career
-
- CTO, YD Life Science Co., Ltd,
- Research Scientist, Korea Institute of Science and Technology
- Senior Research Associate, Duke University Medical Center (USA)
- Edu
-
- POSTECH Life Science Ph.D.
- Profession
-
- RNA Genomics
- Career
-
- Executive Director, YD Life Science
- Korea University Research Professor
SapiensBio
CSO
Dr. Lee, Hyunseung
SapiensBio
CTO
Dr. Yoon, Dong-Oh
- Edu
-
- SNU Pharmacy Ph.D.
- Profession
-
- Pharmacology and Biochemistry
- Career
-
- Executive Director, YD Life Science
- Senior Scientist, Research Institute of Pharmaceutical Science, Seoul National University
- Assistant Research Scientist, Department of Pharmacology University of Texas Health Science Center at San Antonio
- Edu
-
- SungKyunKwan University Pharmacy Ph.D.
- Profession
-
- Medicinal Chemistry
- Career
-
- Principle Research Scientist, JW Pharmaceutical
- Principle Research Scientist, C&C Research Laboratories